Neurocrine Bioscience buy Needham & Company LLC
Start price
06.05.25
/
50%
€112.35
Target price
06.05.26
€123.07
Performance (%)
10.28%
End price
07.05.26
€123.90
Summary
This prediction ended on 07.05.26 with a price of €123.90. The BUY prediction by Needham___Company_LL finished with a performance of 10.28%. Needham___Company_LL has a follow-up prediction for Neurocrine Bioscience where he still thinks Neurocrine Bioscience is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | 15.042% | 15.042% | 23.389% |
| iShares Core DAX® | 0.224% | 1.487% | 3.575% |
| iShares Nasdaq 100 | 6.047% | 16.188% | 39.144% |
| iShares Nikkei 225® | 5.724% | 11.690% | 50.962% |
| iShares S&P 500 | 2.172% | 8.056% | 25.618% |
Comments by Needham___Company_LL for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Needham & Company LLC from $138.00 to $139.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten
Current prediction by Needham___Company_LL for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.40
22.09.25
22.09.25
€144.89
22.09.26
22.09.26
3.90%
08.05.26
08.05.26
Stopped prediction by Needham___Company_LL for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€113.60
06.04.26
06.04.26
€160.60
06.04.27
06.04.27
11.36%
08.05.26
08.05.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€86.30
15.04.25
15.04.25
€121.87
15.04.26
15.04.26
27.81%
16.04.26
16.04.26